Short-Term variability of Vitamin D-related biomarkers

Clinical Chemistry

Volumn 62, Issue 12, 2016, Pages 1647-1653

  Lutsey, Pamela L ^a   Parrinello, Christina M ^b   Misialek, Jeffrey R ^a   Hoofnagle, Andy N ^c   Henderson, Clark M ^c   Laha, Thomas J ^c   Michos, Erin D ^d,e   Eckfeldt, John H ^f   Selvin, Elizabeth ^e  

^a UNIVERSITY OF MINNESOTA   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d JOHNS HOPKINS UNIVERSITY   (United States)

^e JOHNS HOPKINS UNIVERSITY   (United States)

^f UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; ALBUMIN; BIOLOGICAL MARKER; CALCIUM; FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 23; PARATHYROID HORMONE; PHOSPHORUS; VITAMIN D; VITAMIN D BINDING PROTEIN;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; CALCIUM BLOOD LEVEL; COHORT ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LABORATORY TEST; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; PHOSPHATE BLOOD LEVEL; REFERENCE VALUE; BLOOD; METABOLISM; MIDDLE AGED; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BIOMARKERS; FEMALE; HUMANS; MALE; MIDDLE AGED; VITAMIN D;

EID: 85000718019     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2016.261461     Document Type: Article

References (42)

1. Kunutsor S, Apekey T, Steur M. Vitamin D and risk of future hypertension: meta-Analysis of 283, 537 participants. Eur J Epidemiol 2013;28:205-21.
2. Song Y, Wang L, Pittas AG, Del Gobbo LC, Zhang C, Manson JE, Hu FB. Blood 25-hydroxy vitamin D levels and incident type 2 diabetes: A meta-Analysis of prospective studies. Diabetes Care 2013;36:1422-8.
3. Brøndum-Jacobsen P, Benn M, Jensen GB, Nordestgaard BG. 25-hydroxyvitamin D levels and risk of ischemic heart disease, myocardial infarction, and early death: population-based study and meta-Analyses of 18 and 17 studies. Arterioscler Thrombo Vasc Biol 2012; 32:2794-802.
4. Meredith AJ, McManus BM. Vitamin D in heart failure. J Card Fail 2013;19:692-711.
5. Wang L, Song Y, Manson JE, Pilz S, März W, Michaelsson K, et al. Circulating 25-hydroxy-vitaminDand risk of cardiovascular disease: A meta-Analysis of prospective studies. Circ Cardiovasc Qual Outcomes 2012; 5:819-29.
6. Lutsey P, Michos E. Vitamin D, calcium, and atherosclerotic risk: evidence from serum levels and supplementation studies. Curr Atheroscler Rep 2012;15:1-8.
7. Pittas AG, Dawson-Hughes B, Sheehan PR, Rosen CJ, Ware JH, Knowler WC, et al. Rationale and design of the vitamin D and type 2 diabetes (D2D) study: A diabetes prevention trial. Diabetes Care 2014;37:3227-34.
8. Manson JE, Bassuk SS, Lee IM, Cook NR, Albert MA, Gordon D, et al. The vitamin D and omega-3 trial (VITAL): rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular disease. Contemp Clin Trials 2012;33:159-71.
9. LeFevre ML. Screening for vitamin D deficiency in adults: U.S. Preventive Services Task Force recommendation statement screening for vitamin D deficiency in adults. Ann Intern Med 2015;162:133-40.
10. Hoofnagle AN, Eckfeldt JH, Lutsey PL. Vitamin D-binding protein concentrations quantified by mass spectrometry. N Engl J Med 2015;373:1480-2.
11. Henderson CM, Lutsey PL, Misialek JR, Laha TJ, Selvin E, Eckfeldt JH, Hoofnagle AN. Measurement by a novel LC-MS/MS methodology reveals similar serum concentrations of vitamin D-binding protein in blacks and whites. Clin Chem 2016;62:179-87.
12. Roth HJ, Schmidt-Gayk H, Weber H, Niederau C. Accuracy and clinical implications of 7 25-hydroxyvitamin D methods compared with liquid chromatography-Tandem mass spectrometry as a reference. Ann Clin Biochem 2008;45:153-9.
13. Manson JE, Bassuk SS. Vitamin D research and clinical practice: At a crossroads. JAMA 2015;313:1311-2.
14. Gutierrez OM, Farwell WR, Kermah D, Taylor EN. Racial differences in the relationship between vitamin D, bone mineral density, and parathyroid hormone in the National Health and Nutrition Examination Survey. Osteoporos Int 2011;22:1745-53.
15. Rosen C, moderator, Thadhani RI, Millard PS, Rowe SB, panelists. Panel: what is the vitamin D experience? [Panel Discussion]. Vitamin D: Moving Toward Evidence-based Decision Making in Primary Care Conference; 2014 Dec 2-4; Bethesda, MD.
16. Parrinello CM, Grams ME, Sang Y, Couper D, Wruck LM, Li D, et al. Iterative outlier removal: A method for identifying outliers in laboratory recalibration studies. Clin Chem 2016;62:966-72.
17. Lutsey PL, Eckfeldt JH, Ogagarue ER, Folsom AR, Michos ED, Gross M. The 25-hydroxyvitamin D C-3 epimer: Distribution, correlates, and reclassification of 25-hydroxyvitamin D status in the population-based Atherosclerosis Risk in Communities Study (ARIC). Clin Chim Acta 2015;442:75-81.
18. Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 1999;84: 3666-72.
19. Powe CE, Evans MK, Wenger J, Zonderman AB, Berg AH, Nalls M, et al. Vitamin D-binding protein and vitamin D status of black Americans and white Americans. N Engl J Med 2013;369:1991-2000.
20. Parrinello CM, Lutsey PL, Couper D, Eckfeldt JH, Steffes MW, Coresh J, Selvin E. Total short-Term variability in biomarkers of hyperglycemia in older adults. Clin Chem 2015;61:1540-1.
21. Omar F. Essential laboratory knowledge for the clinician. Continuing Medical Education. 2012;30:244-8.
22. Fraser CG. Biological variation: from principles to practice. Washington (DC): AACC Press 2001.
23. Szklo M, Nieto FJ. Epidemiology: beyond the basics. 3rd ed. Burlington (MA): Jones & Bartlett Learning; 2014.
24. Institute of Medicine (US) Committee to Review Dietary Reference Intakes for Vitamin D and Calcium. Dietary reference intakes for calcium and vitamin D. Ross AC, Taylor CL, Yaktine AL, Del Valle HB, editors. Washington (DC): National Academies Press; 2011.
25. Chun RF, Peercy BE, Orwoll ES, Nielson CM, Adams JS, Hewison M. Vitamin D and DPB: The free hormone hypothesis revisited. J Steroid Biochem Mol Biol 2014; 144, Part A:132-7.
26. Petersen PH, Fraser CG, Sandberg S, Goldschmidt H. The index of individuality is often a misinterpreted quantity characteristic. Clin Chem Lab Med 1999;37: 655-61.
27. Vervloet MG, van Ittersum FJ, Büttler RM, Heijboer AC, Blankenstein MA, ter Wee PM. Effects of dietary phosphate and calcium intake on fibroblast growth factor-23.Clin J Am Soc Nephrol 2011;6:383-9.
28. Isakova T, Xie H, Barchi-Chung A, Smith K, Sowden N, Epstein M, et al. Daily variability in mineral metabolites in CKD and effects of dietary calcium and calcitriol. Clin J Am Soc Nephrol 2012;7:820-8.
29. Larsson T, Nisbeth ULF, Ljunggren O, Jüppner H, Jonsson KB. Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers. Kidney Int 2003;64:2272-9.
30. Carpenter TO, Insogna KL, Zhang JH, Ellis B, Nieman S, Simpson C, et al. Circulating levels of soluble klotho and FGF23 in x-linked hypophosphatemia: circadian variance, effects of treatment, and relationship to parathyroid status. J Clin Endocrinol Metab 2010;95: E352-7.
31. Lacher DA, Hughes JP, Carroll MD. Biological variation of laboratory analytes based on the 1999-2002 National Health and Nutrition Examination Survey. Natl Health Stat Report 2010;(21):1-7.
32. Berger C, Greene-Finestone LS, Langsetmo L, Kreiger N, Joseph L, Kovacs CS, et al. Temporal trends and determinants of longitudinal change in 25-hydroxyvitamin D and parathyroid hormone levels. J Bone Miner Res 2012;27:1381-9.
33. van Schoor NM, Knol DL, Deeg DJ, Peters FP, Heijboer AC, Lips P. Longitudinal changes and seasonal variations in serum 25-hydroxyvitamin D levels in different age groups: results of the Longitudinal Aging Study Amsterdam. Osteoporos Int 2014;25:1483-91.
34. Jorde R, Sneve M, Torjesen P, Figenschau Y. No improvement in cardiovascular risk factors in overweight and obese subjects after supplementation with vitamin D3 for 1 year. J Intern Med 2010;267:462-72.
35. McKibben RA, Zhao D, Lutsey PL, Schneider ALC, Guallar E, Mosley TH, Michos ED. Factors associated with change in 25-hydroxyvitamin D levels over longitudinal follow up in the ARIC study. J Clin Endocrinol Metab 2016;101:33-43.
36. Viljoen A, Singh Dhruv K, Twomey Patrick J, Farrington K. Analytical quality goals for parathyroid hormone based on biological variation. Clin Chem Lab Med 2008;46:1438-42.
37. Ankrah-Tetteh T, Wijeratne S, Swaminathan R. Intraindividual variation in serum thyroid hormones, parathyroid hormone and insulin-like growth factor-1. Ann Clin Biochem 2008;45:167-9.
38. Selvin E, Crainiceanu CM, Brancati FL, Coresh J. Shortterm variability in measures of glycemia and implications for the classification of diabetes. Arch Intern Med 2007;167:1545-51.
39. Selvin E, Juraschek SP, Eckfeldt J, Levey AS, Inker LA, Coresh J. Within-person variability in kidney measures. Am J Kidney Dis 2013;61:716-22.
40. Paynter NP, Crainiceanu CM, Sharrett AR, Chambless LE, Coresh J. Effect of correcting for long-Term variation in major coronary heart disease risk factors: relative hazard estimation and risk prediction in the Atherosclerosis Risk in Communities Study. Ann Epidemiol 2012; 22:191-7.
41. Sempos CT, Durazo-Arvizu RA, Binkley N, Jones J, Merkel JM, Carter GD. Developing vitamin D dietary guidelines and the lack of 25-hydroxyvitamin D assay standardization: The ever-present past. J Steroid Biochem Mol Biol [Epub ahead of print 2015 Aug 28].
42. Sempos CT, Vesper HW, Phinney KW, Thienpont LM, Coates PM. Vitamin D status as an international issue: national surveys and the problem of standardization. Scand J Clin Lab Invest Suppl 2012;243:32-40.